• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sinovac Biotech Ltd

+ Add to Watchlist

SVA:US

5.0400 USD 0.0400 0.79%

As of 20:10:00 ET on 11/25/2014.

Snapshot for Sinovac Biotech Ltd (SVA)

Open: 5.0600 Day's Range: 4.9200 - 5.0600 Volume: 52,794
Previous Close: 5.0800 52wk Range: 4.5100 - 8.1400 1-Yr Rtn: -19.62%

Stock Chart for SVA

No chart data available.
  • SVA:US 5.0400
  • 1D
  • 1M
  • 1Y
5.0800
Interactive SVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SVA

Current P/E Ratio (ttm) 82.6704
Estimated P/E(12/2014) -
Relative P/E vs. SPX 4.5222
Earnings Per Share (USD) (ttm) 0.0610
Est. EPS (USD) (12/2014) -0.0550
Est. PEG Ratio -
Market Cap (M USD) 277.66
Shares Outstanding (M) 55.09
30 Day Average Volume 108,336
Price/Book (mrq) 2.2072
Price/Sale (ttm) 4.2638
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SVA

Sinovac Biotech Ltd. researches, develops, manufactures, and markets various vaccines, including flu vaccines and vaccines for Hepatitis A. The Company's products are sold in the Peoples Republic of China and other countries.

Weidong YinChairman/Pres/CEO/Secy/FounderNan WangChief Financial Officer
Ming XiaVP:Sales & Marketing
More Company Profile & Key Executives for SVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil